RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
71 hedge funds and large institutions have $308M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 8 closing their positions.
131% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 16
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
4% more funds holding
Funds holding: 68 → 71 (+3)
17% less capital invested
Capital invested by funds: $372M → $308M (-$64.6M)
56% less call options, than puts
Call options by funds: $6.21M | Put options by funds: $14.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Assured Investment Management
New York
|
+$14.3M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$9.24M |
| 3 |
O
OrbiMed
New York
|
+$8.66M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.58M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$6.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$13.9M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$7.08M |
| 3 |
Millennium Management
New York
|
-$6.4M |
| 4 |
Jane Street
New York
|
-$1.36M |
| 5 |
Goldman Sachs
New York
|
-$1.31M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Tudor Investment Corp
Stamford,
Connecticut
| – | -$157K | -12,049 | Closed |
|
|
PCM
77
Prelude Capital Management
New York
| – | -$28.8K | -1,992 | Closed |
|
|
TRCT
78
Tower Research Capital (TRC)
New York
| – | -$25.3K | -1,753 | -100% |
|
79
BNP Paribas Financial Markets
Paris,
France
| – | -$10.1K | -773 | Closed |
|
RPTP Hedge Fund Activity: Q1 2014 in Review
71 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q1 2014, worth a combined $308M — down 17% from $372M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RPTP positions and 8 closed out — a net gain of 3 holders — while 37 added to existing stakes and 16 trimmed.
The largest buyer was Assured Investment Management, opening a new position worth an estimated $14.3M. The largest seller was Credit Suisse, cutting an estimated $13.9M.
- 71 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q1 2014, up from 68 in Q4 2013.
- Funds reported $308M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q1 2014, down 17% quarter-over-quarter.
- 11 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q1 2014 and 8 closed out, a net change of +3 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q1 2014 was Assured Investment Management, an estimated $14.3M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q1 2014 was Credit Suisse, an estimated $13.9M sold.
Based on aggregated 13F filings for Q1 2014.